One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...
Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...
Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in ...
In a society that has so many people who are overweight, it is understandable there’s such a craze for new drugs that are ...
People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...
In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...
Novo Nordisk’s obesity drug Wegovy is now recommended by EU regulatory authorities for obesity-related heart conditions.
Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...
"Weight loss medications are not one size fits all and patients should always discuss options with a trusted medical professional," one expert told Newsweek.
Novo Nordisk, the maker of Ozempic and Wegovy, said its experimental weight-loss pill lowered participants' body weight by up ...
GLP-1 supplements are advertised as a cheaper alternative to weight loss with Ozempic or Wegovy. Doctors explain if they help ...